Welcome to Skin cancer Guide
Skin Cancer Medicine Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
What to Know about Squamous Cell Skin Cancer
from:Squamous cell skin cancer is one of the three most common forms of skin cancer. This is a cancer that arises in the upper layer of the skin in the squamous cells and is not serious. However, if neglected, this cancer may be difficult to treat and may cause disfigurement.
Causes for squamous cell skin cancer:
It is chronic overexposure to the sun that may cause squamous cell skin cancer. These tumors usually occur on the sun-exposed face, bald scalp, shoulders, hands, arms and back. The most vulnerable places for this cancer are the rim of the ear and the lower lip. The other factors that may contribute to the skin cancer are parts of the skin that has suffered some form of injury like scars, burns and sores and parts of the skin that were exposed to X-rays and certain chemicals like arsenic and petroleum by-products.
Even chronic skin inflammation and medical conditions that suppress the immune system over a span of time encourages the development of skin cancer. In addition to this, long term treatment with immunosuppresive drugs and people with white skin and blond or red hair are more prone to this skin cancer.
Refer chronic inflammatory lesions to a doctor immediately:
Squamous cell skin cancer tumors are thick, horny, and shallow prior to their development. They may ulcerate occasionally to form a raised border and crusted surface on a raised, granular and pebbly base. Bumps in areas of chronic inflammatory skin lesions suggest squamous skin cancer and should be referred to a doctor immediately. The skin in these areas usually has signs of sun damage like loss of elasticity, wrinkling and changes in pigmentation. All suspicious lesions should be examined by a dermatologist, and biopsied if considered necessary. Once skin cancer is diagnosed, treatment options similar to basal cell carcinoma are to be used.
Though most cases of this skin cancer are not dangerous, this cancer grows quickly and may be resistant to treatment so that it damages the healthy skin found around it. In some cases, this cancer may reach the bone and cartilage and with delay in treatment, the cancer is difficult to eliminate and may result in disfigurement.
There is no single method best used for treating squamous cell skin cancer. Different factors are taken into consideration like location, size and if it is a primary or recurrent tumor before the right treatment option is chosen for squamous cell skin cancer. Most treatments are performed in the physician’s office or with special surgical facilities with a local anesthetic.
Skin Cancer Medicine Specific links
Skin Cancer Medicine News
U.S. FDA approves new skin cancer medicine
The United States Food and Drug Administration (FDA) on Monday announced the approval of a drug to treat one of most common types of skin cancer. The FDA approved Erivedge (vismodegib), reviewed under the agency`s priority review program and ahead of the March 8 prescription user fee goal date, to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug ...
Read more...Skin-cancer drug tested in Valley approved by FDA
A new FDA-approved drug gives hope to patients with a type of advanced skin cancer.
Read more...Man's skin cancer takes turn for better with new FDA approved drug
Sidney Theriot, 57, has been fighting basal cell carcinoma skin cancer since he was 27 and says treatment was often painful. "The only thing they were doing before was cutting or scraping or just removing them completely. And you are constantly in stitches, and when they pop up, you have to take them off," Theriot said. He's had multiple surgeries to remove lesions on his face, leg and arm, but ...
Read more...More kids seek tans, may raise skin cancer risk
(Reuters) - As children go from elementary to junior high school, the desire to tan grows stronger while the habit of using sunscreen goes out the window, according to a survey -- potentially raising the risk of getting deadly skin cancer later on. The survey, carried out over three years, found that sunscreen use fell by half, said a study published in the journal Pediatrics, a worrying trend ...
Read more...Roche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says
Roche Holding AG (ROG) ’s melanoma drug Zelboraf speeds growth of another type of skin cancer, researchers said today in a study underscoring the need to test the medicine in combination with a second treatment.
Read more...